Welcome to Markel Corporation's (MKL-NYSE) Investor Relations section.
Markel Corporation markets and underwrites specialty insurance products and programs to a variety of niche markets. In each of these markets, we seek to provide quality products and excellent customer service so that we remain a market leader. Our financial goals are to earn consistent underwriting profits and superior investment returns to build shareholder value.
For more information about Markel Corporation, please click here.
|03/13/18||Markel appoints Julia Chu as Chief Global Ceded Reinsurance Officer|
|RICHMOND, Va., March 13, 2018 /PRNewswire/ -- Markel Corporation (NYSE: MKL) announced today that Julia Chu has been appointed Chief Global Ceded Reinsurance Officer, effective immediately. In this newly created position, Chu will head up Ceded Re functions across Markel's product lines and international insurance operations (71 offices in 21 countries). She will work with executive management to strategically deploy ceded reinsurance in support of Markel's business objectives.
|02/23/18||Beth Hungate-Noland to join Markel Ventures|
|RICHMOND, Va., Feb. 23, 2018 /PRNewswire/ -- Markel Corporation (NYSE: MKL) announced today that Beth Hungate-Noland will join the company as a Managing Director. Hungate-Noland, who has been a Partner at Williams Mullen for the past 15 years, will join the team at Markel that is responsible for the oversight of the company's Markel Ventures operations.
"Beth has been a valued partner of the Markel Ventures family for many years and played an integral role wi... |
|02/21/18||Markel names Patrick Moylan Managing Director, Medical Product Line|
|RICHMOND, Va., Feb. 21, 2018 /PRNewswire/ -- Markel Corporation (NYSE: MKL) announced today that Patrick Moylan has been named Managing Director, Medical Product Line. Moylan is responsible for Markel's product development and underwriting efforts in the health care space.
Alan Rodrigues, Executive Underwriting Officer, Casualty, stated, "Patrick's extensive insurance industry experience and strong broker relationships are invaluable assets for our team. In h... |
|02/06/18||Markel Reports 2017 Financial Results|
|RICHMOND, Va., Feb. 6, 2018 /PRNewswire/ -- Markel Corporation (NYSE: MKL) reported book value per common share outstanding of $683.55 at December 31, 2017, up 13% from $606.30 at December 31, 2016. Over the five-year period ended December 31, 2017, the compound annual growth in book value per common share outstanding was 11%. Comprehensive income to shareholders was $1.2 billion for the year ended December 31, 2017 compared to $667.0 million in 2016. The combined ratio was 105% in 2017 compared... |
|There are currently no events scheduled.|